Mate, don't be salty I called you on your bullshit and Doug's...

Mate, don't be salty I called you on your bullshit and Doug's "comments"

As I previously told you - in 15 minutes the hospital lab tells you which bacterial agent the patient is infected with" "FebriDx is not aimed at Hospitals with direct access to a Pathology lab". - Current complexity status of Febridx requires a lab setting. As long as its a CLIA certified they can do the test - doesn't matter where it is, hospital, university clinic, whatever. You are also just trying to push a position that having access to the biggest GPO in the US is irrelevant as they primarily support hospitals, which just sounds dumb.

That is staff with a qualification. RN, MD, Lab Tech - those that have formal medical training. - Anyone outside the CLIA certified lab in the US are currently unable to use the test, hence the requirement for the CLIA waiver which will drastically increase the addressable market of the product. If any MD/GP was able to use it, then it would already be available to the circa 270,000 offices they are trying to target.

I'll reiterate my point - The company will sell this to anyone who wants to buy it as long as they meet the requirements to purchase it. Regardless of where they work. It doesn't matter if they're targeting a "x" and then "y" wants to purchase the tests.